508017 nor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem

508017
View Pricing & Availability

Overview

Replacement Information

Key Specifications Table

Empirical FormulaCAS #
C₄₀H₄₃N₃O₆·2HCl 105618-26-6

Pricing & Availability

Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
5.08017.0001
Retrieving availability...
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Glass bottle 10 mg
      Retrieving price...
      Price could not be retrieved
      Minimum Quantity needs to be mulitiple of
      Upon Order Completion More Information
      You Saved ()
       
      Request Pricing
      Description
      OverviewA potent antagonist highly selective for κ opioid receptor with no effect on µ- or &delta- opioid receptors. Widely used in studies related to pain, addition, anxiety, depression, and sleep.
      Catalogue Number508017
      Brand Family Calbiochem®
      SynonymsNorbinaltorphimine, nor-BNI, κ Opioid Receptor Antagonist, nor-Binaltorphimine
      References
      ReferencesKishioka, S., et al. 2013. Neurosci. Letters. In press.
      Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44.
      Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255.
      Product Information
      CAS number105618-26-6
      FormWhite to off-white solid
      Hill FormulaC₄₀H₄₃N₃O₆·2HCl
      Chemical formulaC₄₀H₄₃N₃O₆·2HCl
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetkappa opioid receptor
      Purity≥98% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      nor-Binaltorphimine Dihydrochloride - CAS 105618-26-6 - Calbiochem SDS

      Title

      Safety Data Sheet (SDS) 

      References

      Reference overview
      Kishioka, S., et al. 2013. Neurosci. Letters. In press.
      Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44.
      Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision13-March-2017 JSW
      SynonymsNorbinaltorphimine, nor-BNI, κ Opioid Receptor Antagonist, nor-Binaltorphimine
      DescriptionA potent antagonist highly selective for κ opioid receptor with no effect on µ- or &delta- opioid receptors. Widely used in studies related to pain, addition, anxiety, depression, and sleep.
      FormWhite to off-white solid
      CAS number105618-26-6
      Chemical formulaC₄₀H₄₃N₃O₆·2HCl
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityH₂O (50 mM)
      Storage -20°C
      Protect from light
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesKishioka, S., et al. 2013. Neurosci. Letters. In press.
      Valdez, G., et al. 2012. Pharma. Biochem. and Behavior. 102, 44.
      Takemori AE et al. 1988. J. Pharmacol. Exp. Ther. 246, 255.